scispace - formally typeset
M

Min Wang

Researcher at Fourth Military Medical University

Publications -  20
Citations -  608

Min Wang is an academic researcher from Fourth Military Medical University. The author has contributed to research in topics: Neuroprotection & Medicine. The author has an hindex of 9, co-authored 13 publications receiving 396 citations.

Papers
More filters
Journal ArticleDOI

Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway

TL;DR: Findings provide evidence that AKBA protects neurons against ischemic injury, and this neuroprotective effect involves the Nrf2/HO-1 pathway.
Journal ArticleDOI

Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis.

TL;DR: IP showed better colitis recovery and might be the optimum MSCs delivery route for the treatment of DSS-induced colitis, and the IP injection showed the highest survival rate and displayed the less weight loss and quick weight gain.
Journal ArticleDOI

Silibinin Prevents Autophagic Cell Death upon Oxidative Stress in Cortical Neurons and Cerebral Ischemia-Reperfusion Injury.

TL;DR: It is demonstrated that SLB promoted neuron viability upon hydrogen peroxide (H2O2) challenge and reduced hypoxia/ischemia injury in the middle cerebral artery occlusion (MCAO) mouse model and opened new avenues for the use of SLB in treatment of central nervous system (CNS) diseases in which oxidative stress plays a major role in disease pathogenesis.
Journal ArticleDOI

Systemic inflammation induces anxiety disorder through CXCL12/CXCR4 pathway.

TL;DR: Findings provide direct evidence that alterations of CXCL12 in BLA play critical roles in the development of anxiety induced by systemic inflammation and that CXCR4 may be a potential therapeutic target for inflammation-induced anxiety.
Journal ArticleDOI

Enhanced Neuroprotection of Acetyl-11-Keto-β-Boswellic Acid (AKBA)-Loaded O-Carboxymethyl Chitosan Nanoparticles Through Antioxidant and Anti-Inflammatory Pathways

TL;DR: The results suggest that AKBA-NPs serve as a potent delivery vehicle for AKBA in cerebral ischemic therapy and modulate antioxidant and anti-inflammatory pathways more effectively than AKBA.